<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Certain <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorders</z:e> can occur in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and thromboembolic complications are frequent </plain></SENT>
<SENT sid="1" pm="."><plain>We report the case of a 53-Year-old patient with metastatic <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the lung treated with chemotherapy who presented several cerebral arterial <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> leading to <z:hpo ids='HP_0011420'>death</z:hpo> a few weeks after the initial diagnosis of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>This case illustrates the important role of certain satellite disorders related to coagulation activation: non-<z:mp ids='MP_0001794'>bacterial</z:mp> thrombotic <z:hpo ids='HP_0100584'>endocarditis</z:hpo>, <z:hpo ids='HP_0005521'>disseminated intravascular coagulation</z:hpo>, anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibody syndrome </plain></SENT>
<SENT sid="3" pm="."><plain>The role of anticancer chemotherapy as a favoring factor for <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> is also emphasized in patients with <z:e sem="disease" ids="C0007131" disease_type="Neoplastic Process" abbrv="NSCLC">non-small-cell lung cancer</z:e> </plain></SENT>
</text></document>